RFNHX
Price
$100.25
Change
-$0.56 (-0.56%)
Updated
Jul 24 closing price
Net Assets
181.21B
VSMPX
Price
$333.15
Change
+$0.08 (+0.02%)
Updated
Jul 24 closing price
Net Assets
2.3T
Interact to see
Advertisement

RFNHX vs VSMPX

RFNHX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
RFNHX vs. VSMPX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RFNHX is a Hold and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. RFNHX (181B). VSMPX pays higher dividends than RFNHX: VSMPX (1.06) vs RFNHX (0.75). RFNHX was incepted earlier than VSMPX: RFNHX (11 years) vs VSMPX (11 years). RFNHX (0.43) is less costly to investors than VSMPX (0.02). RFNHX is a more actively managed with annual turnover of: 26.00 vs. VSMPX (3.00). RFNHX has a lower initial minimum investment than VSMPX: RFNHX (250) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 16.93 vs. RFNHX (13.10). VSMPX return over 5 years is better than : 61.15 vs. RFNHX (36.17).
RFNHXVSMPXRFNHX / VSMPX
Total Expense Ratio0.430.022,150%
Annual Report Gross Expense Ratio0.430.022,150%
Fund Existence11 years11 years-
Gain YTD9.8658.847111%
Front LoadN/AN/A-
Min. Initial Investment2501000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets181B2.3T8%
Annual Yield % from dividends0.751.0670%
Returns for 1 year13.1016.9377%
Returns for 3 years48.7461.2880%
Returns for 5 years36.1761.1559%
Returns for 10 years97.81230.5642%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDDYX41.410.34
+0.83%
Columbia Dividend Income Inst3
RMBJX25.400.02
+0.08%
RMB C
WCEYX22.71-0.07
-0.31%
Nomura Core Equity Fund Class Y
TBDCX12.98-0.08
-0.61%
PGIM Jennison Diversified Growth C
GTMTX23.20-0.22
-0.94%
Goldman Sachs Small/Mid Cap Growth Inv